A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: TSL-1502 capsules(low dose)|DRUG: TSL-1502 capsules(high dose)|DRUG: Investigator's choice of chemotherapy
Sponsor: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.